Advancing Eye Health with the Science and Technology of Corneal Cross-Linking

  • CEO: Reza Zadno
  • Location: Waltham, MA
  • Milestones: Mar 2013 - Third Point Ventures co-leads Series D, Nov 2019 - Avedro acquired by Glaukos (NYS: GKOS)
Go to site

Avedro is a medical device and pharmaceutical company advancing the science and technology of corneal cross-linking.